Emily Hill
Chief Financial Officer
CFO
Board Member
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Replimune Group, Inc. (REPL) | Chief Financial Officer | $516,500 | $1,594,953 |
| 2024 | Replimune Group, Inc. (REPL) | Chief Financial Officer | $266,538 | $3,383,157 |
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Financial Officer | $367,530 | $2,336,648 |
Executive changes
Earnings-call appearances
-
Replimune Group, Inc. Q4 FY2025 Earnings Call2025-05-22
Replimune Group, Inc. (REPL)
-
Ptc Therapeutics, Inc. Q1 FY2023 Earnings Call2023-04-27
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q3 FY2022 Earnings Call2022-10-27
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-03
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q4 FY2021 Earnings Call2022-01-10
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q3 FY2021 Earnings Call2021-10-28
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q2 FY2021 Earnings Call2021-07-29
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q4 FY2020 Earnings Call2021-01-11
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q3 FY2020 Earnings Call2020-10-29
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-05
Ptc Therapeutics, Inc. (PTCT)
-
Ptc Therapeutics, Inc. Q1 FY2020 Earnings Call2020-04-30
Ptc Therapeutics, Inc. (PTCT)